Abstract
Endocrine disrupting chemicals (EDCs) affect the internal endocrine functions in human and thus effective analytical methods have been developed in recent years. In particular, quantification of EDCs in human biological fluids is essential to obtain direct information about the health risk associated with exposure to these compounds. High performance liquid chromatography (HPLC) has often been applied to the measurement of relatively polar EDCs for instance bisphenol A, phytoestrogen and phthalte metabolites in human biological samples. For detection of EDCs by HPLC, several detection methods such as ultraviolet, fluorescence, electrochemical detection and mass spectrometry are used. These detection methods are selected appropriately in consideration to their sensitivity and selectivity, and characteristics of analytes. Recently, the use of tandem mass spectrometry has increased owing to its excellent specificity. These HPLC methods are used in combination with a suitable sample preparation technique to remove large amounts of complex matrices that interfere with the detection of trace amounts of EDCs in biological fluids and to obtain sufficiently clean chromatogram. We summarized the detection and preparation method for the HPLC determination of EDCs and their metabolites in various human biological fluids such as blood, urine and breast milk.
Keywords: Endocrine disrupting chemicals, High performance liquid chromatography, Pretreatment, Detection method
Current Analytical Chemistry
Title: Human Biomonitoring of Endocrine Disrupting Chemicals by HPLC Methods
Volume: 2 Issue: 1
Author(s): Naoya Kishikawa, Kaname Ohyama and Naotaka Kuroda
Affiliation:
Keywords: Endocrine disrupting chemicals, High performance liquid chromatography, Pretreatment, Detection method
Abstract: Endocrine disrupting chemicals (EDCs) affect the internal endocrine functions in human and thus effective analytical methods have been developed in recent years. In particular, quantification of EDCs in human biological fluids is essential to obtain direct information about the health risk associated with exposure to these compounds. High performance liquid chromatography (HPLC) has often been applied to the measurement of relatively polar EDCs for instance bisphenol A, phytoestrogen and phthalte metabolites in human biological samples. For detection of EDCs by HPLC, several detection methods such as ultraviolet, fluorescence, electrochemical detection and mass spectrometry are used. These detection methods are selected appropriately in consideration to their sensitivity and selectivity, and characteristics of analytes. Recently, the use of tandem mass spectrometry has increased owing to its excellent specificity. These HPLC methods are used in combination with a suitable sample preparation technique to remove large amounts of complex matrices that interfere with the detection of trace amounts of EDCs in biological fluids and to obtain sufficiently clean chromatogram. We summarized the detection and preparation method for the HPLC determination of EDCs and their metabolites in various human biological fluids such as blood, urine and breast milk.
Export Options
About this article
Cite this article as:
Kishikawa Naoya, Ohyama Kaname and Kuroda Naotaka, Human Biomonitoring of Endocrine Disrupting Chemicals by HPLC Methods, Current Analytical Chemistry 2006; 2 (1) . https://dx.doi.org/10.2174/157341106775197394
DOI https://dx.doi.org/10.2174/157341106775197394 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Myocardial Infarction with Non Obstructive Coronary Atherosclerosis: A Case Report
New Emirates Medical Journal Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases
Current Pharmaceutical Design The Secreted Aspartic Proteinases as a New Target in the Therapy of Candidiasis
Current Drug Targets Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry PGC-1α and Exercise: Important Partners in Combating Insulin Resistance
Current Diabetes Reviews Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets A Case-Control Study Investigating the Effect of MTHFR C677T Variant on Performance of Elite Athletes
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Insulin in Glucose-Stimulated Insulin Secretion in Beta Cells
Current Diabetes Reviews Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Endothelial Progenitor Cells as Potential Drug Targets
Current Drug Targets - Cardiovascular & Hematological Disorders Host-Pathogen Interactions in Latent Mycobacterium tuberculosis Infection: Identification of New Targets for Tuberculosis Intervention
Endocrine, Metabolic & Immune Disorders - Drug Targets The Use of n-3 Polyunsaturated Fatty Acids as Therapeutic Agents for Inflammatory Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
Current Pharmaceutical Design Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors
Current Pharmaceutical Design Q Fever and Coxiella burnetii: Immune Response and Pathogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)